Congress expands small-business R&D funding but bars firms working on fact-checking and misinformati

What it does

The INNOVATE Act expands and restructures federal small-business research funding (SBIR and STTR programs) by increasing allocations to participating agencies, creating a new Phase 1A entry program for first-time applicants, raising award caps, and adding security screening tied to foreign relationships and sanctions lists. It also removes existing diversity/equity preferences in favor of rural-area and new-entrant emphasis, and bars funding to firms with agreements involving fact-checking or content-credibility entities (NewsGuard, Global Disinformation Index, Internews).

Why we flagged it

The bill's primary mechanism is expanding SBIR/STTR funding and access (Phase 1A, higher caps, rural outreach), but it also introduces foreign-risk screening tied to sanctions lists and bars funding to firms engaged in fact-checking/content-credibility work—a dual character of expansion plus ideological/security restriction.

• Section 203–204 bars SBIR/STTR funding to firms with agreements involving NewsGuard, Global Disinformation Index, Internews, or entities that rate credibility of domestic news outlets—unrelated to core R&D expansion purpose.

What the text implies

• Removal of explicit race/gender/ethnicity diversity criteria may reduce funding to historically underrepresented groups in STEM, despite rural/new-entrant emphasis potentially offsetting this.
• Foreign-risk definition (10-year lookback on any foreign affiliation, licensing, joint venture, co-authorship) is extremely broad and may deter legitimate international research collaboration and academic partnerships.
• Fact-checking/content-credibility funding bar may chill research into misinformation detection, election security, and media literacy—areas of public interest—by making firms ineligible if they partner with credibility-rating entities.
• Indefinite recovery authority for national-security reasons (beyond 10-year standard) gives agencies open-ended clawback power over intellectual property, creating uncertainty for small-business investors.
• Phase 1A program (1.5–3% of SBIR funding) is new entrant-focused but capped at $40,000 award—may be insufficient to attract serious innovation or compete with larger Phase II awards.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands R&D funding access for rural and first-time small-business innovators, lowering barriers and increasing competition—a public benefit. However, it removes explicit diversity protections (race, gender, ethnicity) in favor of rural/new-entrant criteria, which may narrow opportunity for historically excluded groups; and it bars funding to firms with agreements involving fact-checking or content-credibility entities, which may chill legitimate speech-related research and creates a ch

Who stands to gain

• small businesses in rural areas
• first-time SBIR/STTR applicants
• defense contractors and national-security-focused firms (via expanded Phase II strategic breakthroug
• venture capital and private-equity firms investing in SBIR/STTR recipients (via best-practices guida

Named in the bill

Small Business Administration (SBA), National Institutes of Health (NIH), Department of Defense (DoD), NewsGuard Technologies, Inc., Global Disinformation Index, Internews, Committee on Foreign Investment in the United States (CFIUS), White House Office of Science and Technology Policy, Bureau of Industry and Security (BIS), Office of Foreign Assets Control (OFAC), Federal Communications Commission (FCC), U.S. Customs and Border Protection (CBP)

Where it stands

1 cosponsor: 1 Republicans.

• Jul 25, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jul 25, 2025 — Referred to House Committee on Science, Space, and Technology and House Committee on Small Business · Congress.gov: “Referred to the Committee on Small Business, and in addition to the Committee on Science, Space, and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

6 lobbying clients named this bill on 7 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,812,137 in lobbying spend. A filing names 8 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 82% of bills with at least one filing.

Roger Williams, the sponsor, reported $529,851 in PAC receipts in the 2026 cycle.

• Biotechnology Innovation Organization — $2,360,000 on 1 filing
• Lmi Consulting, LLC — $210,000 on 2 filings
• Paralyzed Veterans of America — $112,137 on 1 filing
• Rise8 — $50,000 on 1 filing
• Activate Global, Inc. — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.